538 related articles for article (PubMed ID: 14559102)
21. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
[TBL] [Abstract][Full Text] [Related]
22. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
Leach K; Sexton PM; Christopoulos A
Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
[TBL] [Abstract][Full Text] [Related]
23. Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators.
Farmer JP; Mistry SN; Laughton CA; Holliday ND
FASEB J; 2022 Nov; 36(11):e22576. PubMed ID: 36183332
[TBL] [Abstract][Full Text] [Related]
24. Allosteric properties of G protein-coupled receptor oligomers.
Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
[TBL] [Abstract][Full Text] [Related]
25. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
Presland J
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
[TBL] [Abstract][Full Text] [Related]
26. Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR; Sexton PM; Christopoulos A
J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
[TBL] [Abstract][Full Text] [Related]
27. [G-protein-coupled receptors targeting: the allosteric approach].
Sebag JA; Pantel J
Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
[TBL] [Abstract][Full Text] [Related]
28. GPCR Allosteric Modulator Discovery.
Wu Y; Tong J; Ding K; Zhou Q; Zhao S
Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
[TBL] [Abstract][Full Text] [Related]
29. Allosteric modulation of G-protein coupled receptors.
Jensen AA; Spalding TA
Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
[TBL] [Abstract][Full Text] [Related]
30. Allosteric communication pipelines in G-protein-coupled receptors.
Vaidehi N; Bhattacharya S
Curr Opin Pharmacol; 2016 Oct; 30():76-83. PubMed ID: 27497048
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
Hudson BD; Ulven T; Milligan G
Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
[TBL] [Abstract][Full Text] [Related]
33. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
Langmead CJ; Christopoulos A
Trends Pharmacol Sci; 2006 Sep; 27(9):475-81. PubMed ID: 16889837
[TBL] [Abstract][Full Text] [Related]
34. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5.
Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151
[TBL] [Abstract][Full Text] [Related]
35. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
36. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
Lütjens R; Rocher JP
Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
[TBL] [Abstract][Full Text] [Related]
38. Ligand detection in the allosteric world.
Kenakin TP
J Biomol Screen; 2010 Feb; 15(2):119-30. PubMed ID: 20086210
[TBL] [Abstract][Full Text] [Related]
39. Functional and structural perspectives on allosteric modulation of GPCRs.
Langmead CJ; Christopoulos A
Curr Opin Cell Biol; 2014 Apr; 27():94-101. PubMed ID: 24680434
[TBL] [Abstract][Full Text] [Related]
40. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
Hurevich M; Talhami A; Shalev DE; Gilon C
Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
